IL1B and diabetes mellitus: More and more evidence shows upregulation of IL-1beta in serum and pancreatic islets from diabetes [14, 15]; furthermore, genetic or pharmacologic inhibition of IL-1beta system has been shown to improve beta-cell function, insulin secretion, and glycemic control in proof-of-concept clinical studies and animal experiments [16–19].